Back to search

Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer

Data up to Jan 2025

Published1996
Citations22
References30

Total Citations Per Year

Abstract

References (30)

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1983 • 52,849 citations

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

1986 • 4,785 citations

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase

1975 • 2,622 citations

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1992 • 1,530 citations

Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

1986 • 962 citations

Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history

1990 • 846 citations

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

1992 • 511 citations

One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants

1991 • 455 citations

Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health

1993 • 420 citations

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

1994 • 420 citations

Clinical effects and toxicity of interleukin-2 in patients with cancer

1986 • 359 citations

In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.

1988 • 356 citations

In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.

1993 • 233 citations

Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.

1994 • 224 citations

A new class of Escherichia coli recBC mutants: implications for the role of RecBC enzyme in homologous recombination.

1984 • 194 citations

Hepatic Resection of Metastasis from Colorectal Carcinoma

1989 • 170 citations

A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.

1993 • 161 citations

Hepatic resection for secondary neoplasms.

1982 • 138 citations

Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase

1992 • 125 citations

Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.

1989 • 111 citations

Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor.

1989 • 83 citations

Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Interleukin-2 (National Institutes of Health)

1992 • 43 citations

Purification and some properties of cytosine deaminase from Salmonella typhimurium

1982 • 31 citations

Purine and pyrimidine transport and permeation in human erythrocytes

1987 • 24 citations

Metabolism and actions of 2‐deoxy‐2‐fluoro‐<scp>d</scp>‐galactose in vivo

1990 • 21 citations

A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer

1993 • 11 citations

A phase 2 trial of recombinant interleukin-2 and 5-fluorouracil in patients with metastatic colorectal carcinoma.

1992 • 6 citations

Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase II study.

1992 • 4 citations

Regional application of cytokines: Experience with various clinical protocols

1992 • 1 citations

Cited By (0)

Loading...
Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer (1996) – Journal of Surgical Oncology | Metascience Observatory Explorer